25P Evaluation of PD-L1 and Ki67 markers in CTCs of NSCLC patients treated with pembrolizumabM. Spiliotaki,H. Charalambous,C.M. Neophytou, G. Gregoriou,P. Vogazianos,C. Deltas,A.I. ConstantinouJournal of Thoracic Oncology(2021)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要